1. Home
  2. GIB vs RVTY Comparison

GIB vs RVTY Comparison

Compare GIB & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CGI Inc.

GIB

CGI Inc.

HOLD

Current Price

$62.19

Market Cap

12.8B

ML Signal

HOLD

Logo Revvity Inc.

RVTY

Revvity Inc.

HOLD

Current Price

$113.52

Market Cap

11.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIB
RVTY
Founded
1976
1937
Country
Canada
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.8B
11.6B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
GIB
RVTY
Price
$62.19
$113.52
Analyst Decision
Hold
Buy
Analyst Count
3
16
Target Price
$112.00
$109.67
AVG Volume (30 Days)
418.6K
1.4M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.70%
0.34%
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
N/A
$3,311,822,000.00
Revenue This Year
$8.33
$6.37
Revenue Next Year
$2.96
$5.10
P/E Ratio
$13.59
$294.15
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$81.22
52 Week High
$106.68
$118.30

Technical Indicators

Market Signals
Indicator
GIB
RVTY
Relative Strength Index (RSI) 37.64 69.85
Support Level $61.35 $90.57
Resistance Level $70.68 $118.30
Average True Range (ATR) 1.95 4.02
MACD -0.42 0.62
Stochastic Oscillator 29.02 93.35

Price Performance

Historical Comparison
GIB
RVTY

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.

About RVTY Revvity Inc.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Share on Social Networks: